Chi Wang

5.6k total citations
155 papers, 3.9k citations indexed

About

Chi Wang is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Chi Wang has authored 155 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 107 papers in Molecular Biology, 30 papers in Cancer Research and 20 papers in Oncology. Recurrent topics in Chi Wang's work include Gene expression and cancer classification (18 papers), RNA modifications and cancer (14 papers) and Epigenetics and DNA Methylation (13 papers). Chi Wang is often cited by papers focused on Gene expression and cancer classification (18 papers), RNA modifications and cancer (14 papers) and Epigenetics and DNA Methylation (13 papers). Chi Wang collaborates with scholars based in United States, China and United Kingdom. Chi Wang's co-authors include Hao Wu, B. Mark Evers, Zhijin Wu, Heidi L. Weiss, Binhua P. Zhou, Jinpeng Liu, Tiebang Kang, Piotr Rychahou, Rafael A. Irizarry and Terence P. Speed and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Chi Wang

144 papers receiving 3.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chi Wang United States 32 2.5k 726 531 300 294 155 3.9k
Hexin Chen China 30 1.8k 0.7× 725 1.0× 975 1.8× 235 0.8× 197 0.7× 186 3.4k
Jun Wan United States 39 2.7k 1.1× 568 0.8× 611 1.2× 519 1.7× 229 0.8× 181 4.8k
Sander R. Piersma Netherlands 40 2.8k 1.1× 852 1.2× 687 1.3× 170 0.6× 297 1.0× 137 4.7k
Jason W.H. Wong Australia 42 2.9k 1.1× 576 0.8× 429 0.8× 342 1.1× 173 0.6× 151 5.0k
Meiling Zhang China 36 3.3k 1.3× 1.3k 1.8× 243 0.5× 204 0.7× 211 0.7× 209 4.8k
Jin Yu China 32 2.4k 0.9× 726 1.0× 221 0.4× 376 1.3× 143 0.5× 156 3.7k
Bo Li China 32 1.6k 0.6× 903 1.2× 685 1.3× 139 0.5× 332 1.1× 184 3.3k
Jun Wu China 26 2.1k 0.8× 769 1.1× 258 0.5× 280 0.9× 218 0.7× 128 3.6k
Hong Chen China 38 2.6k 1.0× 1.6k 2.2× 328 0.6× 213 0.7× 457 1.6× 190 4.4k

Countries citing papers authored by Chi Wang

Since Specialization
Citations

This map shows the geographic impact of Chi Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chi Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chi Wang more than expected).

Fields of papers citing papers by Chi Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chi Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chi Wang. The network helps show where Chi Wang may publish in the future.

Co-authorship network of co-authors of Chi Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Chi Wang. A scholar is included among the top collaborators of Chi Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chi Wang. Chi Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Yanquan, Jinghui Liu, Daheng He, et al.. (2025). The kinase PLK1 promotes Hedgehog signaling–dependent resistance to the antiandrogen enzalutamide in metastatic prostate cancer. Science Signaling. 18(878). eadi5174–eadi5174. 5 indexed citations
2.
Wang, Chi, G. Branduardi‐Raymont, C. P. Escoubet, & C. Forsyth. (2025). Solar Wind Magnetosphere Ionosphere Link Explorer (SMILE): Science and Mission Overview. Space Science Reviews. 221(1). 9–9. 6 indexed citations
3.
Zhou, Jie, Chi Wang, Zhaoyang Zhang, Yifan Feng, & Shaozhong Zeng. (2025). Research progress of aqueous binders for sulfur cathode in lithium-sulfur battery. Journal of Power Sources. 654. 237843–237843.
4.
Xie, Yanqi, Jinpeng Liu, Li Chen, et al.. (2024). A Probabilistic Approach to Estimate the Temporal Order of Pathway Mutations Accounting for Intra-Tumor Heterogeneity. Cancers. 16(13). 2488–2488. 2 indexed citations
6.
Wang, Xiaoqiu, et al.. (2024). Association between sleep-related phenotypes and gut microbiota: a two-sample bidirectional Mendelian randomization study. Frontiers in Microbiology. 15. 1341643–1341643. 8 indexed citations
7.
Chen, Fan, Jinpeng Liu, Robert M Flight, et al.. (2023). Polycomb deficiency drives a FOXP2-high aggressive state targetable by epigenetic inhibitors. Nature Communications. 14(1). 336–336. 8 indexed citations
8.
Tripathi, R. P., Daheng He, Yuanyuan Wu, et al.. (2023). ABL1/2 and DDR1 Drive MEKi Resistance in NRAS-Mutant Melanomas by Stabilizing RAF/MYC/ETS1 and Promoting RAF Homodimerization. Cancers. 15(3). 954–954. 3 indexed citations
9.
Zhang, Zhuangzhuang, Lijun Cheng, Jie Li, et al.. (2022). Targeting Plk1 Sensitizes Pancreatic Cancer to Immune Checkpoint Therapy. Cancer Research. 82(19). 3532–3548. 36 indexed citations
10.
Miller, Rachel W., Heidi L. Weiss, Jianrong Wu, et al.. (2022). Molecular Tumor Board–Assisted Care in an Advanced Cancer Population: Results of a Phase II Clinical Trial. JCO Precision Oncology. 6(6). e2100524–e2100524. 21 indexed citations
11.
Zhang, Shulin, Nan Lin, James W. Keck, et al.. (2022). Real-World Evaluation of a Population Germline Genetic Screening Initiative for Family Medicine Patients. Journal of Personalized Medicine. 12(8). 1297–1297. 3 indexed citations
12.
Liu, Jinpeng, Robert M Flight, Xiulong Song, et al.. (2021). Cellular Origins of EGFR‐Driven Lung Cancer Cells Determine Sensitivity to Therapy. Advanced Science. 8(22). e2101999–e2101999. 15 indexed citations
13.
14.
Tian, Suyan, Jinmei Wang, Qi Zhou, et al.. (2020). A Prognostic Model to Predict Recovery of COVID-19 Patients Based on Longitudinal Laboratory Findings. Virologica Sinica. 35(6). 811–819. 5 indexed citations
15.
Lei, Hongxing, et al.. (2020). Single-cell RNA-Seq revealed profound immune alteration in the peripheral blood of patients with bacterial infection. International Journal of Infectious Diseases. 103. 527–535. 19 indexed citations
16.
Escott, Edward J., et al.. (2019). Dose Reduction While Preserving Diagnostic Quality in Head CT: Advancing the Application of Iterative Reconstruction Using a Live Animal Model. American Journal of Neuroradiology. 40(11). 1864–1870. 3 indexed citations
17.
Hensley, Patrick J., et al.. (2019). Predictive value of phenotypic signatures of bladder cancer response to cisplatin-based neoadjuvant chemotherapy. Urologic Oncology Seminars and Original Investigations. 37(9). 572.e1–572.e11. 12 indexed citations
18.
Wang, Chi, Hui He, Jiu‐liang Zhang, Xing Li, & Zhili Ma. (2015). High performance liquid chromatography (HPLC) fingerprints and primary structure identification of corn peptides by HPLC-diode array detection and HPLC-electrospray ionization tandem mass spectrometry. Journal of Food and Drug Analysis. 24(1). 95–104. 14 indexed citations
19.
Valentino, Joseph, Jing Li, Yekaterina Y. Zaytseva, et al.. (2014). Cotargeting the PI3K and RAS Pathways for the Treatment of Neuroendocrine Tumors. Clinical Cancer Research. 20(5). 1212–1222. 53 indexed citations
20.
Xiong, Gaofeng, Chi Wang, B. Mark Evers, Binhua P. Zhou, & Ren Xu. (2012). RORα Suppresses Breast Tumor Invasion by Inducing SEMA3F Expression. Cancer Research. 72(7). 1728–1739. 94 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026